Nuclear Factor-κB Is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma

Cancer Research - United States
doi 10.1158/0008-5472.can-04-0852
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Nuclear Factor-κB Activity by Small Interfering RNA in Esophageal Squamous Cell Carcinoma Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2011English

Phenotype of Tumor Lymphatic Vessels Is a Prognostic Factor in Human Tongue Squamous Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2010English

An Immunohistochemical Study of Altered Immunomodulatory Molecule Expression in Head and Neck Squamous Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1997English

Gene Expression Profiles Identify Epithelial-To-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-Risk Head and Neck Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2006English

PD-L1 Expression in Tumor Cells Is an Independent Unfavorable Prognostic Factor in Oral Squamous Cell Carcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas

American Journal of Pathology
Forensic MedicinePathology
2000English

Prognostic Value of Nuclear Survivin Expression in Oesophageal Squamous Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2003English

Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients With Squamous Cell Carcinoma of the Lung

PLoS ONE
Multidisciplinary
2013English

Nuclear Beta Catenin Expression Is Related to Unfavourable Outcome in Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy